Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kevin Curry"'
Autor:
Kevin Curry
Publikováno v:
Hatfield Graduate Journal of Public Affairs, Vol 1, Iss 1 (2016)
Externí odkaz:
https://doaj.org/article/a66fe086ba994e228d635e094926f4d9
Autor:
Rosalina Gawryla, Kevin Curry, Jr.
Publikováno v:
Journal of Agricultural Education. 63:39-58
Global society has major scientific challenges to solve over the coming decades including climate change and food insecurity. Considering school-based agricultural education can play an important role in developing scientifically literate and civical
Autor:
Kevin Curry, Jonathan Ulmer
Systems of education intentionally evaluate students and teachers in the teaching and learning process. For many of the same reasons, the case can be made that programs should undergo systematic evaluation to discover where and how growth can occur.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72a6b9a336180b430663b87998c08eff
https://doi.org/10.4018/978-1-6684-3420-8.ch011
https://doi.org/10.4018/978-1-6684-3420-8.ch011
Publikováno v:
2013 ASEE Annual Conference & Exposition Proceedings.
Publikováno v:
2014 ASEE Annual Conference & Exposition Proceedings.
Autor:
Kevin Curry
The fitness influencer and creator of the #1 bestselling Food & Drink app, FitMenCook, shares 100 easy, quick meal prep recipes that will save you time, money, and inches on your waistline—helping you to get healthy on your own terms.We like to be
Autor:
Kevin Curry
The fitness influencer and creator of the bestselling Food & Drink app, FitMenCook, shares 100 easy, quick meal prep recipes that will save you time, money, and inches on your waistline - helping you to get healthy on your own terms. We like to be in
Autor:
F. William Freimuth, Hernan Valdez, Thomas R. MacGregor, Marie Borin, Douglas L. Mayers, Scott McCallister, Kevin Curry, Yenyung Wang
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 35(4)
Tipranavir (TPV), a novel nonpeptidic protease inhibitor (NPPI), was administered to treatment-naive HIV-1-infected patients over 14 days in a randomized, multicenter, open-label, parallel-group trial to evaluate the efficacy and tolerability of a se
Publisher Summary Tipranavir is a potent, highly selective, orally bioavailable, non-peptidic protease inhibitor (NPPI). Tipranavir suppresses the replication of laboratory and clinical HIV-1 strains in primary peripheral blood mononuclear cells. Tip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::994baa25409257fe090f3f015a0bac39
https://doi.org/10.1016/s1075-8593(03)04003-6
https://doi.org/10.1016/s1075-8593(03)04003-6
Autor:
Aron D. Bartle, Larry E. Ramey, Raymond Weinig, Glen H. Wheless, Cathy M. Lascara, Kevin Curry, Russ Burgette, Mike Jenson
Publikováno v:
SPIE Proceedings.
We describe our continuing work on the development and use of collaborative virtual environments (CVEs) in support of mission rehearsal activities for the very shallow water mine countermeasures mission. These multi-participant CVE's are built from m